Source: The Covexit Podcast
This is the anniversary interview of the landmark session we convened with Dr. Peter McCullough and Dr. Geert Vanden Bossche in March 2021. The two distinguished experts discuss the most current developments and issues with COVID-19, vaccination and early treatment. Specifically discussed by Dr. Geert Vanden Bossche is Omicron and its implications. Despite its short duration, the interview is packed with some of the most relevant information for understanding the possible evolution of COVID-19. Both experts also formulate their most urgent recommendations. The interview is made available in audio only.
Apple Podcast: https://podcasts.apple.com/us/podcast/dr-peter-mccullough-dr-geert-vanden-bossche-the/id1576260405?i=1000554427375
Speaker Podcast: https://www.spreaker.com/user/14399013/mccullough-vandenbossche-audio
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.
Email: info@voiceforscienceandsolidarity.org
.svg){kind=small}
